RAPT Therapeutics (RAPT) Total Liabilities (2020 - 2024)
Historic Total Liabilities for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $13.0 million.
- Therapeutics' Total Liabilities fell 5186.29% to $13.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.0 million, marking a year-over-year decrease of 5186.29%. This contributed to the annual value of $26.3 million for FY2023, which is 2495.37% up from last year.
- Latest data reveals that Therapeutics reported Total Liabilities of $13.0 million as of Q3 2024, which was down 5186.29% from $18.0 million recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Total Liabilities peaked at $27.9 million during Q1 2023, and registered a low of $12.3 million during Q4 2021.
- For the 5-year period, Therapeutics' Total Liabilities averaged around $19.2 million, with its median value being $19.0 million (2020).
- As far as peak fluctuations go, Therapeutics' Total Liabilities skyrocketed by 7169.55% in 2022, and later crashed by 5186.29% in 2024.
- Therapeutics' Total Liabilities (Quarter) stood at $14.8 million in 2020, then dropped by 17.13% to $12.3 million in 2021, then surged by 71.7% to $21.0 million in 2022, then rose by 24.95% to $26.3 million in 2023, then plummeted by 50.71% to $13.0 million in 2024.
- Its Total Liabilities stands at $13.0 million for Q3 2024, versus $18.0 million for Q2 2024 and $25.0 million for Q1 2024.